The Science and FDA Regulation of CBD – What is the Path Forward?

Tuesday, October 20
10:00 AM – 11:00 AM (Central Time)
Location:
CE: 1.0
Level 2- Intermediate
Activity Code: 157672

As client interest in cannabidiol (CBD) continues to grow, health care practitioners are ethically obligated to stay abreast of evolving research, safety, and regulatory developments. Join us as we dig deep into the therapeutic potential and adverse effects of cannabidiol with Dr. Ziva Cooper, Research Director of the UCLA Cannabis Research Initiative. Then hear from Sharon Mayl, Senior Advisor for Policy at FDA about the current safety and regulatory work the Agency is undertaking to keep people safe.

Planned with the Committee for Lifelong Learning

Learning Objectives:

  • Discuss current FDA regulations and safety of CBD with clients.
  • Describe the purpose and function of the endocannabinoid system within the human body and explain how CBD can impact its function.
  • Summarize the state of CBD research by describing the scope, strengths, gaps, and limitations of specific research which could have implications for future medical nutrition therapy guidelines.

Performance Indicator:

  • 8.3.6 Keeps abreast of current nutrition and dietetics
    knowledge and trends.
  • 6.3.8 Interprets, analyzes, synthesizes and critically
    appraises research findings.
  • 8.3.5 Keeps abreast of changes in practice and
    within practice environments that affect scope of
    practice.

    Moderator(s)

  • The Science and FDA Regulation of CBD  What is the Path Forward? -

    Zachari Breeding, MS, RDN, LDN, FAND

    Food Systems Dietitian

    Denver VA Medical Center

  • Speaker(s)

  • The Science and FDA Regulation of CBD  What is the Path Forward? -

    Ziva Cooper, PhD

    Associate Professor, Research Director

    UCLA Cannabis Research Initiative

  • The Science and FDA Regulation of CBD  What is the Path Forward? -

    Sharon Mayl, JD

    Senior Advisor for Policy, Office of Food Policy and Response at FDA

    Food & Drug Administration